The SIRT1 deacetylase is one of the best-studied putative mediators of some of the anti-aging effects of calorie restriction (CR), but its role in CR-dependent lifespan extension has not been demonstrated. We previously found that mice lacking both copies of SIRT1 displayed a shorter median lifespan than wildtype mice on an ad libitum diet. Here, we report that median lifespan extension in CR heterozygote SIRT1 +/− mice was identical (51%) to that observed in wild-type mice, but SIRT1 +/− mice displayed a higher frequency of certain pathologies. Although larger studies in additional genetic backgrounds are needed, these results provide strong initial evidence for the requirement of SIRT1 for the lifespan extension effects of CR, but suggest that its high expression is not required for CR-induced lifespan extension.
Introduction
The discovery that sirtuins influence yeast replicative lifespan more than 10 years ago sparked wide interest about their biological role in aging, age-related diseases, and calorie restriction (CR)-mediated lifespan extension. Although the contribution of SIRT1 in both longevity and CR-mediated lifespan extension in lower organisms is a subject of debate (Kaeberlein et al., 2004; Fabrizio et al., 2005) , there is evidence that SIRT1 plays an important role in delaying or ameliorating the onset of some age-associated diseases (Herranz et al., 2010) . However, the role of SIRT1 in the mediation of CR-dependent lifespan extension in mammals remains elusive and controversial (Fontana et al., 2010; Hayflick, 2010) .
To determine whether SIRT1 modulates the effects of CR on aging in mammals, we subjected 2-5-month-old mice of three different genotypes (SIRT1 +/+ , SIRT1 +/À , and SIRT1
À/À
) that had normal, reduced, or no expression of SIRT1 to either 40% CR or ad libitum (AL) diets. SIRT1 À/À mice on CR displayed a short lifespan (Fig. 1A) (Boily et al., 2008; Li et al., 2008) , whereas CR extended the lifespan of both SIRT1 +/À and SIRT1 +/+ mice by 51% ( Fig. 1A and Table S1 -S2). The deletion of one SIRT1 allele resulted in a trend for decreased maximum lifespan under CR conditions (Fig. 1A) . These results indicate that high expression of SIRT1 is not required for the lifespan extension caused by CR.
To address how SIRT1 heterozygosity affects its expression, we measured SIRT1 expression in the liver. Our data show that, under both dietary regimes, there was a genotype-associated proportional decrease in SIRT1 expression both at the mRNA and protein levels (Fig. 2) . SIRT1 expression showed a trend of increase in CR compared with AL animals (Fig. 2 ), in agreement with the increase in SIRT1 protein levels reported for mice, rats, and humans (Baur et al., 2012) .
To investigate whether reduced SIRT1 expression in the SIRT1 +/À mice affected the levels of SIRT1-dependent genes altered by CR in the liver, we performed microarray analyses. A comparison of the gene expression profiles from SIRT1 +/+ and SIRT1 +/À genotypes led to the identification of 77 SIRT1-dependent genes (51 upregulated, 26 downregulated, a total change of 19%) and 24 pathways (13 upregulated, 11 downregulated, a total change of 18%) that were altered in response to CR ( Fig. 1B-E ). Decreased SIRT1 expression resulted in a dose-dependent change in many genes and pathways (Fig. S1 , for a complete list of genes see Table S3 ). Many of the CR-and SIRT1-affected genes are involved in metabolic homeostasis, cell cycle, inflammation, and stress response/ detoxification pathways, areas in which SIRT1 is known to have beneficial effects. Among them, GCK, IRS2, and several members of the major urinary protein (MUPs) family were altered by CR in a SIRT1 gene-dose-dependent manner. These findings were further confirmed using RT-qPCR (Fig. S2A ). GCK, a key enzyme in the glycogen biosynthesis pathway and a proposed target for the development of CR mimetics (Ingram & Roth, 2011) , was downregulated in response to CR. Concurrent with these changes, there was an upregulation of IRS2, an integrator of insulin receptor signals that coordinates metabolism (Dong et al., 2006) . Furthermore, MUP1, which was recently been shown to play an important role in glucose homeostasis (Zhou et al., 2009) , was downregulated in response to CR on both the mRNA (Fig. S2A) and protein (Fig. S2B ) levels. The presence of only one SIRT1 allele was sufficient to cause a major reduction in the expression of many but not all of the CR-affected genes that depend on SIRT1. One could speculate that the genes not affected by the SIRT1 +/À genotype may be responsible for the identical median lifespan observed in the CR SIRT1 +/À and wild-type mice. However, the more likely explanation is that an increased activity or expression of SIRT1 during CR is not required for the anti-aging effects of CR. With our current data set, it remains unclear which of the many SIRT1-affected genes/pathways contribute to the beneficial effects of CR or which particular tissue(s) is/ are mainly responsible for the metabolic/health effects induced by CR. It is also important to note that several SIRT1-independent genes were also altered by CR (Table S4 and S5) . Although CR SIRT1 +/À mice were long-lived, they displayed more frequent defects/pathologies (44% incidence), including eye infections or redness, and abnormal growth compared with CR SIRT1 +/+ mice (31% incidence) (Table S6) . Previous studies have shown that SIRT1-knockout mice displayed defective metabolism, and CR-mediated physiological responses (i.e., increased physical activity) were abrogated (Chen et al., 2005; Boily et al., 2008) . These data confirm the requirement to some degree of SIRT1 expression for the beneficial effects of CR. One point of contention is that SIRT1 À/À mice may die early because they are sick independently of the prolongevity effects of CR. However, CR-mediated lifespan extension is generally observed after 20 months of age in normal mice (Bartke et al., 2001) . Here, the longest-living SIRT1 À/À animals (20% of the initial cohort) were approximately 25 months of age and still were refractory to lifespan extension following CR. These results suggest that some SIRT1 activity or protein levels are required for the effects of CR on health span, possibly because it regulates some of the genes and pathways that are essential for the CR-dependent metabolic responses. Moderate overexpression of SIRT1 in mice on a standard diet has no effect on overall lifespan, yet health span is improved (Herranz et al., 2010) . It is likely that, similar to CR, SIRT1 elicits some beneficial effects on overall health (Bordone et al., 2007) . One possible reason for the absence of lifespan extension in SIRT1-overexpressing mice is that these animals are particularly prone to nonmetabolically related diseases (i.e., lymphoma), independent of SIRT1 dosage (Herranz et al., 2010) . 
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